FORMOTEROL FUMARATE DIHYDRATE

FORMOTEROL FUMARATE DIHYDRATE was reported 97871 times

FORMOTEROL FUMARATE DIHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CFTR GENE MUTATION 15 0.6000
1 HYPER IGE SYNDROME 44 0.3860
2 SALPINGO-OOPHORECTOMY UNILATERAL 36 0.3273
3 TOTAL LUNG CAPACITY ABNORMAL 84 0.2159
4 PULMONARY VASCULITIS 103 0.1914
5 SPIROMETRY ABNORMAL 114 0.1906
6 SPUTUM CULTURE 7 0.1892
7 COCKROACH ALLERGY 9 0.1875
8 CAPILLARITIS 51 0.1848
9 OPTIC NERVE OPERATION 4 0.1600
10 MITE ALLERGY 100 0.1527
11 EJECTION FRACTION 82 0.1411
12 VASCULAR GRAFT INFECTION 6 0.1364
13 MYCOTIC ALLERGY 104 0.1216
14 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 63 0.1205
15 SENSITISATION 91 0.1199
16 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 107 0.1154
17 DUST ALLERGY 112 0.1142
18 ACQUIRED FACTOR V DEFICIENCY 11 0.1000
19 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 73 0.0996
20 NEUROSENSORY HYPOACUSIS 12 0.0992
21 EOSINOPHIL COUNT 11 0.0948
22 COAGULATION FACTOR V LEVEL ABNORMAL 11 0.0894
23 POLYCYSTIC OVARIES 134 0.0863
24 ALVEOLAR OSTEITIS 35 0.0827
25 EOSINOPHILIC BRONCHITIS 16 0.0800
26 URINARY TRACT DISCOMFORT 35 0.0759
27 CONJUNCTIVITIS ALLERGIC 102 0.0688
28 COAGULATION FACTOR DEFICIENCY 11 0.0683
29 INTESTINAL ATONY 4 0.0656
30 RIGHT ATRIAL HYPERTROPHY 7 0.0636
31 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 125 0.0612
32 NEURITIS 91 0.0589
33 SINUSITIS FUNGAL 43 0.0536
34 RESPIRATORY SYMPTOM 150 0.0527
35 LUNG DIFFUSION TEST ABNORMAL 5 0.0515
36 VITAL CAPACITY DECREASED 22 0.0491
37 TOTAL LUNG CAPACITY INCREASED 13 0.0478
38 CONGENITAL HIATUS HERNIA 10 0.0439
39 PRESBYACUSIS 13 0.0422
40 RESTRICTIVE PULMONARY DISEASE 49 0.0418
41 FORCED EXPIRATORY VOLUME ABNORMAL 6 0.0414
42 REVERSIBLE AIRWAYS OBSTRUCTION 21 0.0413
43 EJECTION FRACTION ABNORMAL 49 0.0400
44 B-LYMPHOCYTE COUNT ABNORMAL 4 0.0396
45 OBSTRUCTIVE AIRWAYS DISORDER 430 0.0386
46 EYE PARAESTHESIA 6 0.0382
47 FORCED EXPIRATORY VOLUME DECREASED 106 0.0374
48 TOTAL LUNG CAPACITY DECREASED 59 0.0369
49 ALLERGIC BRONCHITIS 4 0.0360
50 ANIMAL SCRATCH 35 0.0360
51 OBSTRUCTIVE SLEEP APNOEA SYNDROME 52 0.0356
52 PNEUMOCOCCAL INFECTION 21 0.0355
53 SINUS PAIN 78 0.0334
54 VACCINATION SITE PAIN 19 0.0330
55 NORMOCHROMIC NORMOCYTIC ANAEMIA 99 0.0329
56 BALANITIS 4 0.0328
57 NEPHRECTOMY 47 0.0316
58 FULL BLOOD COUNT ABNORMAL 330 0.0312
59 PANCREATIC CALCIFICATION 4 0.0308
60 FACTOR V LEIDEN MUTATION 12 0.0302
61 LUNG OPACITY 79 0.0299
62 BRONCHIECTASIS 199 0.0295
63 PHARYNGITIS BACTERIAL 7 0.0271
64 FEMALE GENITAL TRACT FISTULA 46 0.0269
65 SPUTUM INCREASED 58 0.0268
66 SPUTUM CULTURE POSITIVE 21 0.0259
67 BLOOD ALKALINE PHOSPHATASE ABNORMAL 23 0.0256
68 NASAL MUCOSAL DISCOLOURATION 4 0.0248
69 ALLERGIC GRANULOMATOUS ANGIITIS 20 0.0244
70 RHINITIS ALLERGIC 108 0.0242
71 NASAL POLYPS 115 0.0233
72 BRONCHIAL SECRETION RETENTION 29 0.0228
73 HUMIDITY INTOLERANCE 9 0.0225
74 NASAL OBSTRUCTION 42 0.0224
75 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 4 0.0223
76 VOCAL CORD DYSFUNCTION 11 0.0223
77 SPUTUM DISCOLOURED 202 0.0213
78 LIPOHYPERTROPHY 13 0.0209
79 POLYCYSTIC OVARIAN SYNDROME 8 0.0208
80 PLEURITIC PAIN 57 0.0206
81 BRONCHIAL OBSTRUCTION 28 0.0199
82 RALES 110 0.0189
83 TUNNEL VISION 35 0.0187
84 ALLERGIC SINUSITIS 16 0.0186
85 PANCREATITIS RELAPSING 15 0.0183
86 CHRONIC SINUSITIS 68 0.0181
87 LIP PRURITUS 15 0.0175
88 MYCOBACTERIUM AVIUM COMPLEX INFECTION 46 0.0171
89 PULMONARY ALVEOLAR HAEMORRHAGE 94 0.0167
90 BRONCHIAL HYPERREACTIVITY 20 0.0166
91 BRONCHOSPASM PARADOXICAL 5 0.0166
92 DIASTOLIC DYSFUNCTION 51 0.0165
93 PULMONARY FUNCTION TEST ABNORMAL 25 0.0160
94 BENIGN LUNG NEOPLASM 4 0.0158
95 NEUROLOGICAL SYMPTOM 90 0.0157
96 LUNG CONSOLIDATION 44 0.0157
97 VASCULAR GRAFT OCCLUSION 6 0.0156
98 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 263 0.0155
99 PARANASAL SINUS DISCOMFORT 58 0.0153
100 PULMONARY FUNCTION TEST DECREASED 65 0.0148
101 ARTERIOSCLEROSIS CORONARY ARTERY 98 0.0148
102 EMPHYSEMA 148 0.0147
103 EAR CONGESTION 39 0.0144
104 EMBOLISM VENOUS 43 0.0142
105 BLOOD TEST ABNORMAL 198 0.0141
106 WEANING FAILURE 5 0.0137
107 INCREASED BRONCHIAL SECRETION 35 0.0137
108 OPPOSITIONAL DEFIANT DISORDER 5 0.0127
109 BREAST NEOPLASM 13 0.0126
110 BONE DENSITY INCREASED 5 0.0125
111 BRONCHIAL WALL THICKENING 9 0.0125
112 EOSINOPHIL COUNT INCREASED 98 0.0117
113 VASCULITIS 134 0.0115
114 ALANINE AMINOTRANSFERASE ABNORMAL 24 0.0114
115 BLADDER PAIN 36 0.0113
116 POLYMYALGIA RHEUMATICA 36 0.0113
117 INFECTED DERMAL CYST 4 0.0111
118 LUNG INFECTION PSEUDOMONAL 6 0.0108
119 SLEEP APNOEA SYNDROME 205 0.0107
120 MACROCYTOSIS 12 0.0103
121 BLOOD IMMUNOGLOBULIN E INCREASED 25 0.0103
122 ARTERIOSCLEROSIS 97 0.0103
123 WHEEZING 608 0.0102
124 WOUND COMPLICATION 35 0.0102
125 ASTHMA 1150 0.0102
126 BREATH SOUNDS ABNORMAL 48 0.0097
127 PULMONARY MASS 141 0.0095
128 DRY GANGRENE 6 0.0094
129 DYSLIPIDAEMIA 48 0.0094
130 WOUND SECRETION 37 0.0094
131 MYOCLONIC EPILEPSY 14 0.0092
132 EOSINOPHIL COUNT DECREASED 21 0.0088
133 EFFUSION 12 0.0088
134 ARTHROSCOPY 6 0.0087
135 ANGIOPLASTY 13 0.0087
136 PULMONARY FIBROSIS 165 0.0086
137 MENINGISM 4 0.0085
138 ARTERIOVENOUS FISTULA 4 0.0081
139 BLADDER DISCOMFORT 10 0.0080
140 KYPHOSIS 14 0.0079
141 NODULE 103 0.0079
142 CALCULUS URINARY 12 0.0078
143 MULTIPLE ALLERGIES 61 0.0078
144 RIGHT VENTRICULAR HYPERTROPHY 7 0.0078
145 LIPOMA 20 0.0077
146 HAEMOPTYSIS 214 0.0077
147 BODY FAT DISORDER 4 0.0074
148 ENDOMETRIAL THICKENING 4 0.0072
149 HYPOTHYROIDISM 229 0.0072
150 FUNGAL OESOPHAGITIS 5 0.0071
151 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 46 0.0071
152 BRONCHITIS CHRONIC 17 0.0070
153 BLOOD CALCIUM INCREASED 59 0.0067
154 UPPER RESPIRATORY TRACT INFLAMMATION 8 0.0067
155 CARPAL TUNNEL SYNDROME 93 0.0066
156 CHRONIC RESPIRATORY FAILURE 8 0.0066
157 NASAL INFLAMMATION 7 0.0066
158 DIVERTICULUM 47 0.0066
159 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 461 0.0065
160 PRODUCTIVE COUGH 302 0.0063
161 UTERINE ENLARGEMENT 5 0.0063
162 ANAL INFLAMMATION 4 0.0063
163 HEAT EXHAUSTION 5 0.0062
164 ASPIRATION 66 0.0060
165 BODY TEMPERATURE ABNORMAL 11 0.0060
166 SENSE OF OPPRESSION 7 0.0059
167 ADRENAL SUPPRESSION 5 0.0059
168 HYPOCHROMIC ANAEMIA 6 0.0059
169 CARBON DIOXIDE INCREASED 8 0.0059
170 RHINITIS 47 0.0058
171 UPPER-AIRWAY COUGH SYNDROME 48 0.0058
172 GRANULOMATOSIS WITH POLYANGIITIS 7 0.0058
173 NASAL DISCHARGE DISCOLOURATION 8 0.0058
174 CUSHING'S SYNDROME 4 0.0058
175 TRICUSPID VALVE INCOMPETENCE 45 0.0057
176 SINUS NODE DYSFUNCTION 10 0.0055
177 IRON DEFICIENCY ANAEMIA 50 0.0054
178 CREPITATIONS 16 0.0054
179 THROAT CLEARING 20 0.0053
180 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 253 0.0053
181 RUBBER SENSITIVITY 8 0.0052
182 CYSTITIS NONINFECTIVE 7 0.0052
183 ASTHMATIC CRISIS 19 0.0052
184 STRIDOR 15 0.0051
185 AORTIC VALVE STENOSIS 9 0.0050
186 HYPOXIA 177 0.0050
187 GASTROOESOPHAGEAL REFLUX DISEASE 393 0.0049
188 SENSITIVITY TO WEATHER CHANGE 25 0.0047
189 TERMINAL INSOMNIA 8 0.0045
190 NEPHROPATHY 42 0.0045
191 SUFFOCATION FEELING 11 0.0044
192 B-LYMPHOCYTE COUNT DECREASED 6 0.0044
193 METABOLIC SURGERY 5 0.0044
194 CUSHINGOID 14 0.0044
195 HIATUS HERNIA 56 0.0043
196 HYSTERECTOMY 37 0.0043
197 ISCHAEMIC CARDIOMYOPATHY 13 0.0042
198 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 214 0.0041
199 MYOPATHY 35 0.0040
200 SARCOIDOSIS 19 0.0040
201 PNEUMONIA PSEUDOMONAL 6 0.0039
202 FIBROMYALGIA 95 0.0039
203 LOWER RESPIRATORY TRACT INFECTION 172 0.0038
204 ALLERGY TO ANIMAL 4 0.0038
205 SCLERITIS 6 0.0037
206 VULVOVAGINAL CANDIDIASIS 5 0.0037
207 INFUSION SITE MASS 4 0.0037
208 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
209 SKIN LACERATION 39 0.0036
210 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
211 SINUS DISORDER 70 0.0035
212 PULMONARY CONGESTION 46 0.0035
213 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
214 FOLATE DEFICIENCY 4 0.0035
215 BLOOD IRON DECREASED 41 0.0035
216 SEBORRHOEIC KERATOSIS 5 0.0034
217 RESPIRATORY TRACT INFECTION VIRAL 8 0.0034
218 CANDIDA INFECTION 58 0.0034
219 PULMONARY PAIN 10 0.0034
220 INFUSION SITE DISCHARGE 6 0.0034
221 PAINFUL RESPIRATION 8 0.0033
222 HYPERVENTILATION 19 0.0033
223 INFUSION SITE BRUISING 7 0.0032
224 RESPIRATORY TRACT INFECTION 84 0.0032
225 RESPIRATORY DISORDER 96 0.0032
226 BLOOD PRESSURE SYSTOLIC INCREASED 62 0.0032
227 SYMPTOM RECURRENCE 19 0.0032
228 INAPPROPRIATE AFFECT 5 0.0032
229 PSEUDOMONAS INFECTION 27 0.0031
230 LUNG DISORDER 153 0.0031
231 COMPUTERISED TOMOGRAM ABNORMAL 7 0.0031
232 ABSCESS 49 0.0031
233 HYPOVENTILATION 10 0.0031
234 BODY TEMPERATURE DECREASED 30 0.0030
235 EOSINOPHILIA 53 0.0030
236 FOREIGN BODY SENSATION IN EYES 19 0.0030
237 CHEST X-RAY ABNORMAL 9 0.0029
238 DYSPNOEA EXERTIONAL 110 0.0029
239 PERIPHERAL VASCULAR DISORDER 15 0.0029
240 OSTEOPENIA 44 0.0029
241 SKIN INDURATION 6 0.0029
242 HANGOVER 10 0.0028
243 LIVER FUNCTION TEST INCREASED 61 0.0028
244 VASCULAR OCCLUSION 6 0.0028
245 NEUTROPHILIA 16 0.0028
246 HYPOAESTHESIA ORAL 42 0.0028
247 UPPER RESPIRATORY TRACT INFECTION 128 0.0028
248 URINARY TRACT INFECTION BACTERIAL 7 0.0028
249 NASAL OEDEMA 5 0.0028
250 HYPOKINESIA 40 0.0028
251 OBSTRUCTION 11 0.0028
252 RESTLESS LEGS SYNDROME 50 0.0027
253 SKIN LESION 75 0.0027
254 BRONCHOSPASM 39 0.0027
255 TYPE 2 DIABETES MELLITUS 91 0.0027
256 TRANSAMINASES INCREASED 60 0.0027
257 CORNEAL OEDEMA 6 0.0027
258 SPINAL STENOSIS 11 0.0027
259 HYPERCAPNIA 8 0.0027
260 EAR PAIN 51 0.0026
261 POLYP 17 0.0026
262 COUGH 727 0.0026
263 ORAL CANDIDIASIS 34 0.0026
264 APHTHOUS ULCER 20 0.0026
265 BRONCHIAL DISORDER 4 0.0026
266 INFUSION SITE PRURITUS 8 0.0025
267 VOCAL CORD DISORDER 5 0.0025
268 JOINT INJURY 54 0.0025
269 BLOOD COUNT ABNORMAL 38 0.0025
270 LIMB INJURY 68 0.0025
271 CORONARY ARTERY DISEASE 75 0.0025
272 PARADOXICAL DRUG REACTION 9 0.0024
273 INFUSION SITE HAEMORRHAGE 8 0.0024
274 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 4 0.0024
275 DEMENTIA ALZHEIMER'S TYPE 4 0.0024
276 CHEST DISCOMFORT 245 0.0024
277 RESPIRATORY TRACT CONGESTION 38 0.0024
278 POST-TRAUMATIC STRESS DISORDER 16 0.0024
279 SINUS CONGESTION 32 0.0024
280 EYELID PTOSIS 24 0.0024
281 DYSPNOEA 1334 0.0024
282 NASAL CONGESTION 138 0.0023
283 INFARCTION 16 0.0023
284 ECZEMA 120 0.0023
285 PNEUMONIA FUNGAL 9 0.0023
286 NOSOCOMIAL INFECTION 5 0.0023
287 BLOOD URINE PRESENT 43 0.0023
288 JAUNDICE CHOLESTATIC 8 0.0023
289 OSTEOPOROSIS 93 0.0023
290 ATRIAL FLUTTER 18 0.0023
291 CALCINOSIS 5 0.0022
292 BRONCHITIS 165 0.0022
293 APPARENT DEATH 8 0.0022
294 CHRONIC GASTRITIS 5 0.0022
295 MIDDLE INSOMNIA 41 0.0022
296 SEASONAL ALLERGY 31 0.0022
297 HYPOMANIA 8 0.0022
298 LICHEN PLANUS 5 0.0022
299 HEPATIC NEOPLASM 7 0.0021
300 ANAL HAEMORRHAGE 6 0.0021
301 PROCEDURAL PAIN 59 0.0021
302 LUNG NEOPLASM 9 0.0021
303 DISABILITY 41 0.0021
304 BURNING SENSATION 145 0.0021
305 CONCUSSION 16 0.0021
306 LUMBAR SPINAL STENOSIS 6 0.0021
307 DISEASE RECURRENCE 97 0.0020
308 RENAL DISORDER 95 0.0020
309 REGURGITATION 7 0.0020
310 DERMAL CYST 5 0.0020
311 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
312 OEDEMA 109 0.0020
313 CATHETER SITE HAEMORRHAGE 5 0.0020
314 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
315 PULMONARY EMBOLISM 187 0.0020
316 BODY TEMPERATURE INCREASED 40 0.0020
317 INFUSION SITE SWELLING 12 0.0019
318 HYPERTENSIVE CRISIS 21 0.0019
319 POOR PERIPHERAL CIRCULATION 8 0.0019
320 THROAT IRRITATION 84 0.0019
321 ACUTE RESPIRATORY FAILURE 36 0.0019
322 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16 0.0018
323 SINUSITIS 184 0.0018
324 INFUSION SITE ERYTHEMA 15 0.0018
325 OXYGEN SATURATION ABNORMAL 5 0.0018
326 HYPERCHOLESTEROLAEMIA 17 0.0018
327 BRONCHOPNEUMONIA 6 0.0018
328 THROMBOSIS 140 0.0017
329 FUNGAL INFECTION 58 0.0017
330 CARDIAC MURMUR 15 0.0017
331 FEELING COLD 48 0.0017
332 WOUND 48 0.0017
333 PERFORMANCE STATUS DECREASED 8 0.0017
334 PATELLA FRACTURE 4 0.0017
335 UMBILICAL HERNIA 8 0.0017
336 RHINORRHOEA 110 0.0017
337 SECRETION DISCHARGE 21 0.0017
338 OVERWEIGHT 9 0.0017
339 OEDEMA PERIPHERAL 203 0.0017
340 NORMAL NEWBORN 9 0.0017
341 PNEUMONIA 530 0.0016
342 CYSTIC FIBROSIS 9 0.0016
343 CARDIAC DISORDER 150 0.0016
344 OROPHARYNGEAL PAIN 147 0.0016
345 ESCHERICHIA INFECTION 13 0.0016
346 PARKINSON'S DISEASE 4 0.0016
347 EYE HAEMORRHAGE 21 0.0016
348 EXERCISE TOLERANCE DECREASED 9 0.0016
349 INCREASED UPPER AIRWAY SECRETION 8 0.0016
350 OESOPHAGITIS 17 0.0016
351 BACTERIAL INFECTION 29 0.0016
352 OXYGEN SATURATION DECREASED 87 0.0015
353 VULVOVAGINAL DRYNESS 5 0.0015
354 CHOKING 30 0.0015
355 PARALYSIS 22 0.0015
356 DYSURIA 56 0.0015
357 HYPERTENSION 322 0.0015
358 CONJUNCTIVITIS 28 0.0015
359 CANDIDIASIS 6 0.0015
360 HYPERLACTACIDAEMIA 4 0.0015
361 HYPOACUSIS 64 0.0015
362 STRESS FRACTURE 8 0.0015
363 THERAPY PARTIAL RESPONDER 23 0.0015
364 SNEEZING 33 0.0015
365 URINARY RETENTION 49 0.0015
366 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
367 PANIC ATTACK 53 0.0015
368 RESPIRATION ABNORMAL 10 0.0014
369 FOOD ALLERGY 11 0.0014
370 WRIST FRACTURE 17 0.0014
371 HYPERVOLAEMIA 7 0.0014
372 LUNG TRANSPLANT 5 0.0014
373 HAEMORRHAGIC DIATHESIS 5 0.0014
374 BRAIN INJURY 14 0.0014
375 PANIC REACTION 10 0.0014
376 PYELONEPHRITIS 12 0.0014
377 TOOTH INJURY 6 0.0014
378 DYSPNOEA AT REST 4 0.0014
379 FRUSTRATION TOLERANCE DECREASED 11 0.0014
380 APHONIA 19 0.0014
381 LUNG INFECTION 21 0.0014
382 GLAUCOMA 26 0.0013
383 MOVEMENT DISORDER 43 0.0013
384 BLOOD PRESSURE FLUCTUATION 32 0.0013
385 LIGAMENT SPRAIN 13 0.0013
386 POLLAKIURIA 54 0.0013
387 REHABILITATION THERAPY 5 0.0013
388 INFUSION SITE EXTRAVASATION 8 0.0013
389 APNOEA 10 0.0013
390 BLOOD CREATININE DECREASED 4 0.0013
391 OSTEOARTHRITIS 53 0.0012
392 INFUSION SITE PAIN 16 0.0012
393 PERIORBITAL SWELLING 7 0.0012
394 MUSCLE DISORDER 10 0.0012
395 GOUT 22 0.0012
396 INFLUENZA 136 0.0012
397 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
398 SLEEP DISORDER 86 0.0012
399 CARDIOMYOPATHY 18 0.0012
400 TRANSIENT ISCHAEMIC ATTACK 41 0.0012
401 LISTLESS 4 0.0012
402 OTITIS MEDIA 4 0.0012
403 SOCIAL PROBLEM 5 0.0012
404 DYSPHONIA 70 0.0012
405 DYSARTHRIA 45 0.0012
406 BLOOD CREATININE INCREASED 77 0.0012
407 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
408 CEREBRAL ISCHAEMIA 6 0.0012
409 CONGENITAL ANOMALY 9 0.0012
410 LEFT VENTRICULAR FAILURE 4 0.0012
411 INJECTION SITE VESICLES 7 0.0012
412 PLEURAL EFFUSION 70 0.0011
413 BLOOD LACTIC ACID INCREASED 6 0.0011
414 HAEMATURIA 39 0.0011
415 ATELECTASIS 11 0.0011
416 NEPHROLITHIASIS 52 0.0011
417 SINUS TACHYCARDIA 16 0.0011
418 ANAL FISTULA 6 0.0011
419 HEART RATE INCREASED 111 0.0011
420 POST PROCEDURAL INFECTION 9 0.0011
421 HYPERGLYCAEMIA 40 0.0011
422 ORAL DISORDER 8 0.0011
423 CHOKING SENSATION 6 0.0011
424 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
425 IMMUNODEFICIENCY 16 0.0011
426 DIABETES MELLITUS 81 0.0011
427 LACRIMATION INCREASED 32 0.0011
428 TENDON PAIN 8 0.0011
429 CELLULITIS 53 0.0011
430 PARANASAL SINUS HYPERSECRETION 4 0.0010
431 INJECTION SITE DISCOMFORT 11 0.0010
432 SKIN ATROPHY 6 0.0010
433 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
434 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
435 CERVIX CARCINOMA 4 0.0010
436 ECCHYMOSIS 7 0.0010
437 ACUTE MYOCARDIAL INFARCTION 30 0.0010
438 URINARY INCONTINENCE 30 0.0010
439 CARDIAC FAILURE 81 0.0010
440 BLOOD PRESSURE INCREASED 154 0.0010
441 EXTRASYSTOLES 7 0.0010
442 ANAL INCONTINENCE 9 0.0010
443 SALIVARY HYPERSECRETION 10 0.0010
444 OROPHARYNGEAL DISCOMFORT 9 0.0010
445 INTRACRANIAL ANEURYSM 4 0.0010
446 LARYNGEAL OEDEMA 6 0.0010
447 REBOUND EFFECT 11 0.0010
448 SYNCOPE 97 0.0010
449 BASAL CELL CARCINOMA 15 0.0010
450 NASAL DRYNESS 6 0.0010
451 HOSPITALISATION 145 0.0009
452 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
453 AORTIC VALVE INCOMPETENCE 4 0.0009
454 EAR INFECTION 25 0.0009
455 VITAMIN D DECREASED 8 0.0009
456 BODY HEIGHT DECREASED 10 0.0009
457 BLISTER 52 0.0009
458 BEHAVIOUR DISORDER 5 0.0009
459 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 5 0.0009
460 RESPIRATORY DISTRESS 25 0.0009
461 LIGAMENT RUPTURE 4 0.0009
462 ILLNESS 93 0.0009
463 CARDIAC FAILURE ACUTE 6 0.0009
464 PULMONARY OEDEMA 40 0.0009
465 DRY THROAT 9 0.0009
466 HEART RATE IRREGULAR 20 0.0009
467 TOOTH ABSCESS 9 0.0009
468 PALLOR 24 0.0009
469 ABDOMINAL HERNIA 4 0.0009
470 LUNG NEOPLASM MALIGNANT 36 0.0009
471 ISCHAEMIA 4 0.0009
472 SKIN EXFOLIATION 73 0.0009
473 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
474 GASTRITIS EROSIVE 4 0.0009
475 HEART RATE DECREASED 30 0.0009
476 URINE ODOUR ABNORMAL 5 0.0008
477 RESPIRATORY FAILURE 62 0.0008
478 RENAL PAIN 9 0.0008
479 CHEST PAIN 157 0.0008
480 RETCHING 18 0.0008
481 MYOCARDIAL INFARCTION 147 0.0008
482 CONTUSION 81 0.0008
483 ACCIDENT 10 0.0008
484 MUSCULOSKELETAL STIFFNESS 73 0.0008
485 ANAPHYLACTIC REACTION 46 0.0008
486 ANXIETY 235 0.0008
487 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
488 PERICARDIAL EFFUSION 19 0.0008
489 PNEUMOTHORAX 13 0.0008
490 CONDITION AGGRAVATED 249 0.0008
491 DEEP VEIN THROMBOSIS 53 0.0008
492 THROAT TIGHTNESS 22 0.0008
493 MULTI-ORGAN FAILURE 14 0.0008
494 EXPIRED DRUG ADMINISTERED 4 0.0008
495 ELECTROCARDIOGRAM QT PROLONGED 29 0.0008
496 OCULAR DISCOMFORT 9 0.0008
497 WEIGHT INCREASED 179 0.0008
498 TACHYCARDIA 71 0.0008
499 PAIN IN EXTREMITY 235 0.0008
500 DYSSTASIA 23 0.0008
501 BLOOD PRESSURE DECREASED 52 0.0008
502 NASOPHARYNGITIS 144 0.0008
503 INITIAL INSOMNIA 8 0.0008
504 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
505 INFLUENZA LIKE ILLNESS 64 0.0008
506 LIMB DISCOMFORT 24 0.0008
507 CHILLS 90 0.0008
508 PLATELET COUNT INCREASED 10 0.0008
509 CARDIAC FAILURE CONGESTIVE 61 0.0008
510 NASAL DISCOMFORT 6 0.0008
511 OBESITY 12 0.0008
512 TREMOR 125 0.0008
513 QUALITY OF LIFE DECREASED 10 0.0007
514 MYASTHENIA GRAVIS 6 0.0007
515 ROAD TRAFFIC ACCIDENT 31 0.0007
516 PHARYNGITIS STREPTOCOCCAL 8 0.0007
517 SPINAL DISORDER 7 0.0007
518 TACHYPNOEA 10 0.0007
519 ASPHYXIA 6 0.0007
520 ABDOMINAL DISTENSION 76 0.0007
521 TOOTH FRACTURE 8 0.0007
522 GASTRIC ULCER HAEMORRHAGE 4 0.0007
523 INTRACRANIAL PRESSURE INCREASED 4 0.0007
524 BALANCE DISORDER 62 0.0007
525 MASS 10 0.0007
526 ANGIOPATHY 4 0.0007
527 SKIN INFECTION 8 0.0007
528 MOBILITY DECREASED 51 0.0007
529 WEIGHT DECREASED 198 0.0007
530 PARAESTHESIA 111 0.0007
531 DEPRESSION 160 0.0007
532 MICTURITION URGENCY 8 0.0007
533 PNEUMONITIS 19 0.0007
534 BACK PAIN 162 0.0007
535 CYSTITIS 22 0.0007
536 SCIATICA 11 0.0007
537 PYREXIA 238 0.0007
538 FAECES SOFT 5 0.0007
539 URINARY TRACT INFECTION 117 0.0007
540 GASTROENTERITIS 10 0.0007
541 ADVERSE EVENT 63 0.0007
542 HYPERCHLORHYDRIA 4 0.0007
543 HYPERSENSITIVITY 126 0.0007
544 MYALGIA 115 0.0007
545 RESPIRATORY RATE INCREASED 6 0.0007
546 CATARACT 40 0.0007
547 STAPHYLOCOCCAL INFECTION 22 0.0007
548 ORAL HERPES 13 0.0007
549 JOINT DISLOCATION 7 0.0007
550 LETHARGY 38 0.0007
551 SCHIZOPHRENIA 8 0.0007
552 NEURALGIA 16 0.0007
553 PNEUMONIA BACTERIAL 6 0.0007
554 PERIPHERAL SWELLING 100 0.0006
555 PALPITATIONS 76 0.0006
556 GENERAL PHYSICAL HEALTH DETERIORATION 75 0.0006
557 GAIT DISTURBANCE 124 0.0006
558 ATRIAL FIBRILLATION 63 0.0006
559 PRODUCT DISTRIBUTION ISSUE 6 0.0006
560 HEADACHE 405 0.0006
561 TOOTH EXTRACTION 8 0.0006
562 LACERATION 6 0.0006
563 FALL 212 0.0006
564 HEPATOCELLULAR INJURY 9 0.0006
565 FRACTURE 12 0.0006
566 DELIRIUM 22 0.0006
567 TINNITUS 29 0.0006
568 HEPATOTOXICITY 14 0.0006
569 ASTHENIA 235 0.0006
570 MUSCULAR WEAKNESS 71 0.0006
571 LOWER LIMB FRACTURE 12 0.0006
572 ANAEMIA 118 0.0006
573 MITRAL VALVE INCOMPETENCE 7 0.0006
574 GASTROENTERITIS VIRAL 11 0.0006
575 HYPOGAMMAGLOBULINAEMIA 4 0.0006
576 LEUKOCYTOSIS 11 0.0006
577 DISCOMFORT 37 0.0006
578 ACUTE CORONARY SYNDROME 5 0.0006
579 HYPOAESTHESIA 90 0.0006
580 HYPERKALAEMIA 21 0.0006
581 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
582 SENSATION OF FOREIGN BODY 5 0.0006
583 ATAXIA 7 0.0006
584 INSURANCE ISSUE 9 0.0006
585 MALAISE 258 0.0006
586 ABNORMAL LOSS OF WEIGHT 4 0.0006
587 MIGRAINE 56 0.0006
588 MACULAR DEGENERATION 7 0.0006
589 PARANOIA 10 0.0006
590 ADRENAL INSUFFICIENCY 7 0.0006
591 PULMONARY HYPERTENSION 12 0.0006
592 LUNG INFILTRATION 5 0.0006
593 LYMPHOCYTE COUNT DECREASED 10 0.0006
594 HAND FRACTURE 4 0.0006
595 KIDNEY INFECTION 11 0.0006
596 ANGINA PECTORIS 16 0.0006
597 BLOOD PRESSURE ABNORMAL 11 0.0006
598 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
599 FATIGUE 425 0.0005
600 SWOLLEN TONGUE 17 0.0005
601 RETINAL DETACHMENT 5 0.0005
602 FOOT DEFORMITY 6 0.0005
603 VIRAL INFECTION 18 0.0005
604 DIPLOPIA 14 0.0005
605 FEELING HOT 33 0.0005
606 HEPATIC ENCEPHALOPATHY 5 0.0005
607 COVID-19 94 0.0005
608 APPENDICITIS 5 0.0005
609 MUSCLE SPASMS 97 0.0005
610 CIRCULATORY COLLAPSE 9 0.0005
611 INFUSION RELATED REACTION 35 0.0005
612 URTICARIA 88 0.0005
613 ACIDOSIS 4 0.0005
614 RASH ERYTHEMATOUS 25 0.0005
615 BOWEL MOVEMENT IRREGULARITY 4 0.0005
616 MOUTH ULCERATION 11 0.0005
617 NEOPLASM 6 0.0005
618 PHARYNGEAL OEDEMA 8 0.0005
619 THYROID DISORDER 8 0.0005
620 CHOLELITHIASIS 17 0.0005
621 ATRIOVENTRICULAR BLOCK 4 0.0005
622 NERVOUSNESS 27 0.0005
623 TENDONITIS 8 0.0005
624 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
625 NEUROPATHY PERIPHERAL 49 0.0005
626 CORONARY ARTERY OCCLUSION 7 0.0005
627 RESPIRATORY ARREST 14 0.0005
628 HAEMOGLOBIN DECREASED 52 0.0005
629 ORAL DISCOMFORT 7 0.0005
630 BLADDER DISORDER 5 0.0005
631 POLYNEUROPATHY 6 0.0005
632 HYPOTONIA 5 0.0005
633 THYROID CANCER 6 0.0005
634 INFECTION 72 0.0005
635 LOCALISED INFECTION 12 0.0005
636 WRONG TECHNIQUE IN DRUG USAGE PROCESS 18 0.0005
637 CONSTIPATION 108 0.0005
638 BACK DISORDER 8 0.0005
639 HICCUPS 4 0.0005
640 HERPES ZOSTER 28 0.0005
641 HYPERCALCAEMIA 6 0.0005
642 PRODUCT USE IN UNAPPROVED INDICATION 120 0.0005
643 POOR VENOUS ACCESS 5 0.0005
644 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
645 DRUG DEPENDENCE 77 0.0005
646 BLOOD SODIUM DECREASED 9 0.0005
647 DIVERTICULITIS 13 0.0005
648 VISUAL IMPAIRMENT 58 0.0005
649 HERNIA 9 0.0005
650 PRODUCT DOSE OMISSION ISSUE 136 0.0005
651 LOSS OF CONSCIOUSNESS 59 0.0005
652 AGGRESSION 23 0.0005
653 ORTHOSTATIC HYPOTENSION 8 0.0005
654 ABDOMINAL PAIN UPPER 94 0.0005
655 MATERNAL EXPOSURE DURING PREGNANCY 40 0.0004
656 MALNUTRITION 5 0.0004
657 GASTROINTESTINAL INFECTION 4 0.0004
658 INFLAMMATION 23 0.0004
659 CYANOSIS 7 0.0004
660 HYPONATRAEMIA 25 0.0004
661 DRY MOUTH 36 0.0004
662 DIZZINESS 221 0.0004
663 GASTROINTESTINAL CARCINOMA 4 0.0004
664 PNEUMONIA ASPIRATION 11 0.0004
665 PSYCHOTIC DISORDER 13 0.0004
666 HAEMORRHAGE 46 0.0004
667 ULCER 7 0.0004
668 EXOSTOSIS 4 0.0004
669 SENSORY DISTURBANCE 7 0.0004
670 DRUG INTOLERANCE 42 0.0004
671 NERVE COMPRESSION 4 0.0004
672 HYPOGLYCAEMIA 21 0.0004
673 LACTIC ACIDOSIS 14 0.0004
674 UNRESPONSIVE TO STIMULI 11 0.0004
675 LEUKAEMIA 4 0.0004
676 COVID-19 PNEUMONIA 5 0.0004
677 ARRHYTHMIA 20 0.0004
678 PRURITUS 162 0.0004
679 BACTERAEMIA 5 0.0004
680 LIP SWELLING 14 0.0004
681 NERVOUS SYSTEM DISORDER 13 0.0004
682 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
683 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
684 NOCTURIA 5 0.0004
685 HALLUCINATION 31 0.0004
686 HEAD INJURY 13 0.0004
687 FEAR 11 0.0004
688 BLOOD CHOLESTEROL INCREASED 19 0.0004
689 MUSCLE SPASTICITY 5 0.0004
690 CARDIOMEGALY 5 0.0004
691 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
692 TENDON RUPTURE 5 0.0004
693 INJECTION SITE SWELLING 31 0.0004
694 ABDOMINAL PAIN 94 0.0004
695 ORAL PAIN 9 0.0004
696 FEELING ABNORMAL 96 0.0004
697 PANCREATITIS ACUTE 9 0.0004
698 DERMATITIS ALLERGIC 5 0.0004
699 APHASIA 12 0.0004
700 DRUG INTERACTION 63 0.0004
701 DYSPEPSIA 39 0.0004
702 MUSCLE ATROPHY 5 0.0004
703 INSOMNIA 105 0.0004
704 FLUID RETENTION 20 0.0004
705 GALLBLADDER DISORDER 7 0.0004
706 DECREASED APPETITE 91 0.0004
707 NEUTROPHIL COUNT INCREASED 4 0.0004
708 GAIT INABILITY 13 0.0004
709 INJECTION SITE BRUISING 31 0.0004
710 ABDOMINAL DISCOMFORT 65 0.0004
711 RASH PRURITIC 21 0.0004
712 C-REACTIVE PROTEIN INCREASED 14 0.0004
713 PAIN 235 0.0004
714 COLITIS ULCERATIVE 17 0.0004
715 GASTRITIS 10 0.0004
716 ARTHRALGIA 158 0.0004
717 VISION BLURRED 52 0.0004
718 ADVERSE DRUG REACTION 34 0.0004
719 DISORIENTATION 15 0.0004
720 INCONTINENCE 4 0.0004
721 RENAL FAILURE ACUTE 16 0.0004
722 NECK PAIN 21 0.0004
723 EATING DISORDER 8 0.0004
724 HEPATIC CIRRHOSIS 7 0.0004
725 NIGHT SWEATS 12 0.0004
726 POOR QUALITY SLEEP 8 0.0004
727 BLOOD BILIRUBIN INCREASED 10 0.0004
728 DEVICE MALFUNCTION 26 0.0004
729 FOOT FRACTURE 7 0.0004
730 DRUG INEFFECTIVE 484 0.0004
731 BLOOD POTASSIUM DECREASED 11 0.0004
732 POST PROCEDURAL COMPLICATION 7 0.0004
733 MUSCULOSKELETAL PAIN 19 0.0004
734 COAGULOPATHY 6 0.0004
735 DRUG ADMINISTRATION ERROR 11 0.0004
736 WITHDRAWAL SYNDROME 15 0.0004
737 EYE PRURITUS 12 0.0004
738 AGITATION 26 0.0004
739 HAEMATOCRIT DECREASED 7 0.0004
740 FLATULENCE 20 0.0004
741 SOMNOLENCE 71 0.0004
742 INTERNAL HAEMORRHAGE 4 0.0003
743 ANOSMIA 5 0.0003
744 HYPERTHYROIDISM 5 0.0003
745 ELECTROLYTE IMBALANCE 4 0.0003
746 SPEECH DISORDER 18 0.0003
747 SWELLING 32 0.0003
748 INJURY 24 0.0003
749 SEPSIS 38 0.0003
750 DEPRESSED MOOD 18 0.0003
751 ANGIOEDEMA 15 0.0003
752 HEAD DISCOMFORT 6 0.0003
753 CARDIO-RESPIRATORY ARREST 14 0.0003
754 EPISTAXIS 25 0.0003
755 ACUTE KIDNEY INJURY 51 0.0003
756 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
757 ECONOMIC PROBLEM 5 0.0003
758 INJECTION SITE PRURITUS 22 0.0003
759 RESTLESSNESS 12 0.0003
760 ERYTHEMA 67 0.0003
761 MENTAL STATUS CHANGES 9 0.0003
762 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
763 MUSCULOSKELETAL CHEST PAIN 5 0.0003
764 FEMUR FRACTURE 10 0.0003
765 FAECES DISCOLOURED 7 0.0003
766 CYST 4 0.0003
767 CONFUSIONAL STATE 52 0.0003
768 DRY EYE 16 0.0003
769 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
770 INJECTION SITE PAIN 98 0.0003
771 HOT FLUSH 24 0.0003
772 RHEUMATOID ARTHRITIS 36 0.0003
773 GASTRIC ULCER 6 0.0003
774 INTENTIONAL DOSE OMISSION 9 0.0003
775 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
776 HAEMATEMESIS 8 0.0003
777 MUSCULOSKELETAL DISORDER 6 0.0003
778 STEVENS-JOHNSON SYNDROME 7 0.0003
779 HYPERSOMNIA 9 0.0003
780 HYPOPHAGIA 8 0.0003
781 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
782 GLOSSODYNIA 7 0.0003
783 HAEMATOMA 8 0.0003
784 BONE PAIN 18 0.0003
785 SWELLING FACE 20 0.0003
786 DIARRHOEA 198 0.0003
787 ASCITES 9 0.0003
788 BEDRIDDEN 4 0.0003
789 IMMUNE SYSTEM DISORDER 4 0.0003
790 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
791 UPPER LIMB FRACTURE 6 0.0003
792 BLOOD UREA INCREASED 5 0.0003
793 NAUSEA 235 0.0003
794 EPILEPSY 9 0.0003
795 INJECTION SITE WARMTH 6 0.0003
796 CARDIAC ARREST 24 0.0003
797 EXPOSURE DURING PREGNANCY 18 0.0003
798 INCORRECT DOSE ADMINISTERED 66 0.0003
799 HYPOTENSION 58 0.0003
800 RASH 126 0.0003
801 HYPOMAGNESAEMIA 4 0.0003
802 ENCEPHALOPATHY 7 0.0003
803 NEOPLASM MALIGNANT 19 0.0003
804 DYSPHAGIA 27 0.0003
805 BLINDNESS UNILATERAL 4 0.0003
806 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
807 EXTRAPYRAMIDAL DISORDER 7 0.0003
808 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
809 SKIN CANCER 6 0.0003
810 UNEVALUABLE EVENT 21 0.0003
811 ABDOMINAL PAIN LOWER 7 0.0003
812 MEMORY IMPAIRMENT 38 0.0003
813 TOOTHACHE 5 0.0003
814 MENTAL DISORDER 12 0.0003
815 BONE DISORDER 5 0.0003
816 END STAGE RENAL DISEASE 5 0.0003
817 OCULAR HYPERAEMIA 13 0.0003
818 HAEMATOCHEZIA 15 0.0003
819 ANAPHYLACTIC SHOCK 7 0.0003
820 BLOOD GLUCOSE ABNORMAL 5 0.0003
821 DEHYDRATION 36 0.0003
822 SKIN DISORDER 9 0.0003
823 TOOTH DISORDER 6 0.0003
824 RASH MACULO-PAPULAR 6 0.0003
825 EYE SWELLING 10 0.0003
826 INTERSTITIAL LUNG DISEASE 13 0.0003
827 HEPATIC STEATOSIS 5 0.0003
828 COLON CANCER 4 0.0003
829 DEAFNESS 7 0.0003
830 DEATH 230 0.0003
831 VOMITING 124 0.0003
832 PRODUCT AVAILABILITY ISSUE 6 0.0003
833 MUSCLE TWITCHING 6 0.0003
834 NIGHTMARE 9 0.0003
835 HYPOKALAEMIA 12 0.0003
836 DELUSION 4 0.0003
837 BRAIN FOG 4 0.0003
838 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
839 PRODUCT PRESCRIBING ERROR 6 0.0003
840 INJECTION SITE ERYTHEMA 31 0.0002
841 RENAL FAILURE 33 0.0002
842 PRODUCT ADMINISTRATION ERROR 5 0.0002
843 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
844 PRESYNCOPE 6 0.0002
845 BLOOD POTASSIUM INCREASED 4 0.0002
846 AMNESIA 16 0.0002
847 ABASIA 6 0.0002
848 JOINT SWELLING 29 0.0002
849 SKIN DISCOLOURATION 11 0.0002
850 INTESTINAL OBSTRUCTION 9 0.0002
851 DERMATITIS 5 0.0002
852 KNEE ARTHROPLASTY 5 0.0002
853 FLUSHING 24 0.0002
854 COGNITIVE DISORDER 11 0.0002
855 HEPATIC ENZYME INCREASED 16 0.0002
856 GASTROINTESTINAL DISORDER 21 0.0002
857 GASTRIC DISORDER 8 0.0002
858 RECTAL HAEMORRHAGE 10 0.0002
859 MUSCULOSKELETAL DISCOMFORT 4 0.0002
860 DRY SKIN 31 0.0002
861 SKIN ULCER 6 0.0002
862 PRURITUS GENERALISED 5 0.0002
863 COMA 11 0.0002
864 SEPTIC SHOCK 10 0.0002
865 PRODUCT PRESCRIBING ISSUE 5 0.0002
866 JOINT STIFFNESS 6 0.0002
867 METASTASES TO LIVER 4 0.0002
868 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
869 FEBRILE NEUTROPENIA 15 0.0002
870 ISCHAEMIC STROKE 4 0.0002
871 FREQUENT BOWEL MOVEMENTS 6 0.0002
872 MOOD ALTERED 6 0.0002
873 SEIZURE 25 0.0002
874 ARTHRITIS 17 0.0002
875 DEMENTIA 6 0.0002
876 STOMATITIS 13 0.0002
877 ILL-DEFINED DISORDER 13 0.0002
878 OSTEONECROSIS 7 0.0002
879 INCREASED APPETITE 4 0.0002
880 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
881 DRUG PRESCRIBING ERROR 4 0.0002
882 DYSTONIA 4 0.0002
883 DRUG EFFECT DECREASED 11 0.0002
884 DYSGEUSIA 15 0.0002
885 HYPERHIDROSIS 26 0.0002
886 RASH MACULAR 7 0.0002
887 ABORTION SPONTANEOUS 8 0.0002
888 IRRITABILITY 12 0.0002
889 PREMATURE BABY 6 0.0002
890 THERAPEUTIC RESPONSE DECREASED 12 0.0002
891 LYMPHADENOPATHY 7 0.0002
892 DYSKINESIA 8 0.0002
893 HEPATITIS 5 0.0002
894 MYELOSUPPRESSION 7 0.0002
895 OFF LABEL USE 170 0.0002
896 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
897 SEDATION 5 0.0002
898 IRRITABLE BOWEL SYNDROME 4 0.0002
899 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
900 CEREBROVASCULAR ACCIDENT 31 0.0002
901 INTENTIONAL PRODUCT MISUSE 16 0.0002
902 IMPAIRED HEALING 6 0.0002
903 MELAENA 4 0.0002
904 VISUAL ACUITY REDUCED 6 0.0002
905 ARTHROPATHY 10 0.0002
906 PANCYTOPENIA 10 0.0002
907 PLATELET COUNT DECREASED 19 0.0002
908 ABNORMAL BEHAVIOUR 7 0.0002
909 PAIN IN JAW 5 0.0002
910 RED BLOOD CELL COUNT DECREASED 5 0.0002
911 EYE IRRITATION 10 0.0002
912 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
913 NO ADVERSE EVENT 31 0.0002
914 CHRONIC KIDNEY DISEASE 13 0.0002
915 THROMBOCYTOPENIA 19 0.0002
916 RHABDOMYOLYSIS 7 0.0002
917 DISTURBANCE IN ATTENTION 9 0.0002
918 RENAL IMPAIRMENT 14 0.0002
919 CRYING 6 0.0002
920 BLOOD GLUCOSE INCREASED 31 0.0002
921 EMOTIONAL DISORDER 5 0.0002
922 PRODUCT QUALITY ISSUE 22 0.0002
923 MEDICATION ERROR 9 0.0002
924 OSTEONECROSIS OF JAW 4 0.0002
925 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
926 AGEUSIA 4 0.0002
927 PRODUCT STORAGE ERROR 14 0.0002
928 GASTRIC CANCER 4 0.0002
929 ALOPECIA 31 0.0002
930 CARDIOVASCULAR DISORDER 4 0.0002
931 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
932 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
933 HIP FRACTURE 5 0.0002
934 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
935 NEUTROPENIA 21 0.0002
936 EXPOSURE VIA SKIN CONTACT 4 0.0002
937 PRODUCT USE ISSUE 29 0.0002
938 EYE DISORDER 5 0.0002
939 PANCREATITIS 8 0.0002
940 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
941 BLINDNESS 6 0.0001
942 NEUTROPHIL COUNT DECREASED 6 0.0001
943 EYE PAIN 8 0.0001
944 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
945 CONVULSION 8 0.0001
946 UNDERDOSE 10 0.0001
947 LIVER DISORDER 6 0.0001
948 INJECTION SITE MASS 5 0.0001
949 THERAPY NON-RESPONDER 6 0.0001
950 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
951 VERTIGO 8 0.0001
952 SKIN IRRITATION 6 0.0001
953 INJECTION SITE REACTION 9 0.0001
954 BONE DENSITY DECREASED 4 0.0001
955 DRUG-INDUCED LIVER INJURY 4 0.0001
956 TREATMENT FAILURE 10 0.0001
957 LEUKOPENIA 6 0.0001
958 BLADDER CANCER 7 0.0001
959 ANGER 4 0.0001
960 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
961 DEVICE DISLOCATION 5 0.0001
962 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
963 DERMATITIS ATOPIC 6 0.0001
964 THERAPY INTERRUPTED 8 0.0001
965 CEREBRAL HAEMORRHAGE 4 0.0001
966 SKIN BURNING SENSATION 8 0.0001
967 TREATMENT NONCOMPLIANCE 6 0.0001
968 DEPENDENCE 6 0.0001
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
970 COMPLETED SUICIDE 9 0.0001
971 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
972 PRODUCT DOSE OMISSION 7 0.0001
973 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
974 COLITIS 4 0.0001
975 SUICIDAL IDEATION 9 0.0001
976 DRUG DOSE OMISSION 16 0.0001
977 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
978 EMOTIONAL DISTRESS 10 0.0001
979 ACNE 6 0.0001
980 DISEASE PROGRESSION 9 0.0001
981 BRADYCARDIA 4 0.0001
982 OVERDOSE 16 0.0001
983 INJECTION SITE HAEMORRHAGE 5 0.0001
984 PROSTATE CANCER 5 0.0001
985 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
986 DEVICE ISSUE 5 0.0001
987 BREAST CANCER 5 0.0001
988 PSORIASIS 7 0.0001
989 TOXICITY TO VARIOUS AGENTS 9 0.0001
990 DRUG DOSE OMISSION BY DEVICE 4 0.0001
991 DRUG ABUSE 4 0.0000
992 DRUG WITHDRAWAL SYNDROME 4 0.0000